How is the Checkpoint Therapeutics Inc today?

The Checkpoint Therapeutics Inc today is trading in the down by 0.00% at 4.18.

What is Checkpoint Therapeutics Inc Annual Revenue?

Checkpoint Therapeutics Inc Annual Revenue fell 60.19%, in the last year to $0.04 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Checkpoint Therapeutics Inc Annual Net Profit?

Checkpoint Therapeutics Inc Annual Net Profit fell 8.47% in the last year to $56.24 M. Its sector's average net profit growth for the last fiscal year was -11.04%.

What is Checkpoint Therapeutics Inc Price to Earning Ratio?

Checkpoint Therapeutics Inc Price to Earning Ratio is -6.44, which is negative.

What is Checkpoint Therapeutics Inc Stock Price?

Checkpoint Therapeutics Inc Stock Price rose 110.05% and outperformed its sector by 97.66% in the past year.

What is Checkpoint Therapeutics Inc Quarterly Net profit?

Checkpoint Therapeutics Inc Quarterly Net profit fell 2.44% YoY to $11.21 M. Its sector's average net profit growth YoY for the quarter was -212.78%.

What is Checkpoint Therapeutics Inc Mutual Fund Holding?

Checkpoint Therapeutics Inc Mutual Fund Holding decreased by 1.95% in the last quarter to 6.26.

What is Checkpoint Therapeutics Inc Promoter Share Holding?

Checkpoint Therapeutics Inc Promoter Share Holding decreased by 0.39% in the most recent quarter to 18.25%.

What is Checkpoint Therapeutics Inc Institutional Holding?

Checkpoint Therapeutics Inc Institutional Holding increased by 1.22% in the last quarter to 14.23.

Checkpoint Therapeutics Inc XNAS: CKPT

Checkpoint Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Checkpoint Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Checkpoint Therapeutics Inc
Rating: 1.42200
Author: Trendlyne DVM scores

about

Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the USA. It focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid...

4.18 0.00 (0.00%)

138.86% Gain from 52W Low

1.6M XNAS Volume

XNAS 22 May, 2025 12:31 PM (EDT)

Not Eligible

-

Expensive Valuation

0.0 / 100

Technically Neutral

56.9 / 100

4

1Yr Price target upside is 4%

3 analysts

Checkpoint Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Checkpoint Therapeutics Inc FAQ

How is Checkpoint Therapeutics Inc today?

Checkpoint Therapeutics Inc today is trading in the red, and is down by 0.00% at 4.18.

How has Checkpoint Therapeutics Inc performed historically?

Checkpoint Therapeutics Inc is currently trading down 0.00% on an intraday basis. In the past week the stock rose 0.72%. stock has been up 33.55% in the past quarter and rose 110.05% in the past year. You can view this in the overview section.